We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$276M
AUM Growth
+$4.77M
Cap. Flow
-$2.47M
Cap. Flow %
-0.9%
Top 10 Hldgs %
47.16%
Holding
229
New
12
Increased
65
Reduced
101
Closed
20

Top Buys

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$1.23M
2
ENVX icon
Enovix
ENVX
+$782K
3
VRT icon
Vertiv
VRT
+$628K
4
PFE icon
Pfizer
PFE
+$508K
5
AAPL icon
Apple
AAPL
+$500K

Sector Composition

Rank Sector Weight
1 Technology 27.93%
2 Healthcare 20.12%
3 Communication Services 8.24%
4 Financials 6.51%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
176
Cigna
CI
$74.5B
$228K 0.08%
689
GS icon
177
Goldman Sachs
GS
$314B
$226K 0.08%
500
SCYX icon
178
SCYNEXIS
SCYX
$42.4M
$223K 0.08%
13,938
-375
-3% -$5.8K
HMC icon
179
Honda
HMC
$36.5B
$222K 0.08%
6,874
-199
-3% -$6.73K
SMCI icon
180
Super Micro Computer
SMCI
$15.6B
$221K 0.08%
+2,700
New +$231K
ET icon
181
Energy Transfer Partners
ET
$69.9B
$219K 0.08%
13,514
+2,800
+26% +$44K
IBDQ
182
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$217K 0.08%
8,746
IWB icon
183
iShares Russell 1000 ETF
IWB
$48B
$215K 0.08%
723
CRM icon
184
Salesforce
CRM
$140B
$215K 0.08%
835
-20
-2% -$5.35K
AZN icon
185
AstraZeneca
AZN
$262B
$213K 0.08%
+1,363
New +$205K
CL icon
186
Colgate-Palmolive
CL
$74.4B
$210K 0.08%
+2,167
New +$200K
FCX icon
187
Freeport-McMoran
FCX
$83.9B
$207K 0.07%
+4,254
New +$214K
DUK icon
188
Duke Energy
DUK
$97.5B
$204K 0.07%
+2,032
New +$203K
FYC icon
189
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.43B
$201K 0.07%
3,057
-215
-7% -$14K
CHI
190
Calamos Convertible Opportunities and Income Fund
CHI
$1.03B
$199K 0.07%
17,056
-3,071
-15% -$34.6K
FXN icon
191
First Trust Energy AlphaDEX Fund
FXN
$393M
$191K 0.07%
10,500
CATX icon
192
Perspective Therapeutics
CATX
$341M
$173K 0.06%
17,350
+5,600
+48% +$81K
AUTL
193
Autolus Therapeutics
AUTL
$383M
$171K 0.06%
49,000
+8,000
+20% +$34.5K
HA
194
DELISTED
Hawaiian Holdings, Inc.
HA
$155K 0.06%
12,500
-2,000
-14% -$26.1K
ETJ
195
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$561M
$152K 0.06%
17,322
-1,500
-8% -$12.7K
XAIR icon
196
Beyond Air
XAIR
$4.02M
$138K 0.05%
641
-382
-37% -$190K
STXS icon
197
Stereotaxis
STXS
$154M
$131K 0.05%
72,060
BCS icon
198
Barclays
BCS
$93.8B
$107K 0.04%
10,000
VVR icon
199
Invesco Senior Income Trust
VVR
$456M
$100K 0.04%
23,275
+1,570
+7% +$6.74K
BYRN icon
200
Byrna Technologies
BYRN
$75.8M
$99.8K 0.04%
10,000

Similar funds

Wealth Effects's Q2 2024 Portfolio in Review

As of Q2 2024, Wealth Effects held 229 positions worth $276M, up 1.8% from $271M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Wealth Effects's Q2 2024 filing shows 12 new, 65 increased, 101 reduced and 20 closed positions. Its largest new stake was Datadog: 10,160 shares worth $1.32M. The largest sale was CVS Health, an estimated $657K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.

  • Wealth Effects's largest Q2 2024 buy was Datadog: 10,160 shares worth $1.32M.
  • Wealth Effects added most to Enovix in Q2 2024, an estimated $782K increase.
  • Wealth Effects's biggest Q2 2024 reduction was CVS Health, cutting an estimated $657K.
  • Wealth Effects fully exited Shopify in Q2 2024, selling an estimated $551K.
  • Wealth Effects's ten largest holdings make up 47% of its $276M portfolio in Q2 2024.
  • Wealth Effects opened 12 new positions and closed 20 in Q2 2024.
  • Wealth Effects's portfolio value rose 1.8% quarter-over-quarter to $276M.

Based on Wealth Effects's 13F filing for Q2 2024, filed 2 Aug 2024.